Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Voyageur Pharmaceuticals (VYYRF)

OTHER OTC:VYYRF

VYYRF

Voyageur Pharmaceuticals

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding VYYRF?

Track your performance easily

Link Broker

Voyageur Pharmaceuticals (VYYRF) Income Statement

2 Followers

Voyageur Pharmaceuticals Income Statement

Last quarter (Q ), Voyageur Pharmaceuticals's total revenue was C$―, a decrease of ― from the same quarter last year. In Q, Voyageur Pharmaceuticals's net income was C$-273.60K. See Voyageur Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Nov 23	Nov 22	Nov 21	Nov 20	Nov 19
Total Revenue	-	-	-	-	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	C$ 1.35M	C$ 1.35M	C$ 1.75M	C$ 2.05M	C$ 1.00M	C$ 554.89K
Operating Income	C$ -1.35M	C$ -1.35M	C$ -1.75M	C$ -2.05M	C$ -1.00M	C$ -554.89K
Net Non Operating Interest Income Expense	-	-	-	-	-	-
Other Income Expense	C$ 53.09K	C$ 53.09K	C$ 1.97K	-	C$ -138.38K	C$ 2.60K
Pretax Income	C$ -1.40M	C$ -1.40M	C$ -1.75M	C$ -2.05M	C$ -1.14M	C$ -552.29K
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -1.40M	C$ -1.40M	C$ -1.75M	C$ -2.05M	C$ -1.14M	C$ -552.29K
Basic EPS	-	C$ -0.01	C$ -0.02	C$ -0.02	C$ -0.02	C$ -0.01
Diluted EPS	-	C$ -0.01	C$ -0.02	C$ -0.02	C$ -0.02	C$ -0.01
Basic Average Shares	C$ 522.02M	C$ 130.50M	C$ 107.83M	C$ 94.68M	C$ 70.53M	C$ 57.54M
Diluted Average Shares	C$ 522.02M	C$ 130.50M	C$ 107.83M	C$ 94.68M	C$ 70.53M	C$ 57.54M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 1.13M	-	C$ 1.75M	C$ -2.05M	C$ 1.00M	C$ 554.89K
Net Income From Continuing And Discontinued Operation	C$ -1.40M	C$ -1.40M	C$ -1.75M	C$ -2.05M	C$ -1.14M	C$ -552.29K
Normalized Income	C$ -931.39K	C$ -980.00K	C$ -1.28M	C$ -1.51M	C$ -987.32K	C$ -552.29K
Interest Expense	-	-	-	-	-	-
EBIT	C$ -1.40M	C$ -1.40M	C$ -1.75M	C$ -2.05M	C$ -1.00M	C$ -554.89K
EBITDA	C$ -1.40M	C$ -1.40M	C$ -1.74M	C$ -2.05M	C$ -999.56K	C$ -552.77K

Currency in CAD

Voyageur Pharmaceuticals Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing